{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:33:50Z","timestamp":1787582030348,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clinbiochem.2021.06.007","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T11:10:13Z","timestamp":1625137813000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes"],"prefix":"10.1016","volume":"96","author":[{"given":"Amany M.","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7711-0473","authenticated-orcid":false,"given":"Eman F.","family":"Wasfey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4180-6046","authenticated-orcid":false,"given":"Wesam R.","family":"Elghamry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-9652","authenticated-orcid":false,"given":"Omar M.","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9668-7895","authenticated-orcid":false,"given":"Hany A.","family":"Elghobary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinbiochem.2021.06.007_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13304-016-0359-y","article-title":"Worldwide burden of colorectal cancer: a review","volume":"68","author":"Favoriti","year":"2016","journal-title":"Updates Surg."},{"issue":"2019","key":"10.1016\/j.clinbiochem.2021.06.007_b0010","first-page":"1941","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0020","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.3390\/ijms21155311","article-title":"Biomarkers in colorectal cancer: current research and future prospects","volume":"21","author":"Ogunwobi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00018-020-03581-0","article-title":"Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance","volume":"78","author":"Wei","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.06.007_b0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/imcb.1003","article-title":"Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells","volume":"96","author":"Sasidharan Nair","year":"2018","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0050","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1073\/pnas.0830997100","article-title":"Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients","volume":"100","author":"Hodi","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0055","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ni1144","article-title":"B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator","volume":"6","author":"Sedy","year":"2005","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.06.007_b0065","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/mt.2011.88","article-title":"Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice","volume":"19","author":"Lasaro","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.06.007_b0075","doi-asserted-by":"crossref","first-page":"e30676","DOI":"10.1371\/journal.pone.0030676","article-title":"TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression","volume":"7","author":"Gao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0080","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1172\/JCI31184","article-title":"LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems","volume":"117","author":"Grosso","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.clinbiochem.2021.06.007_b0085","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/eji.200526090","article-title":"Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells","volume":"35","author":"Kisielow","year":"2005","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0090","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.4049\/jimmunol.0903879","article-title":"LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites","volume":"184","author":"Camisaschi","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0095","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.2147\/CMAR.S253369","article-title":"Biochemical markers of colorectal cancer \u2013 present and future","volume":"12","author":"Jelski","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/path.2774","article-title":"Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review","volume":"222","author":"Nosho","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fimmu.2017.00619","article-title":"Intratumoral FoxP3(+)Helios(+) regulatory T cells upregulating immunosuppressive molecules are expanded in human colorectal cancer","volume":"8","author":"Syed Khaja","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3892\/ijo.2020.5062","article-title":"High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer","volume":"57","author":"Kitsou","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0120","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00262-020-02593-w","article-title":"Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer","volume":"69","author":"Saleh","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41422-020-0277-x","article-title":"The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity","volume":"30","author":"Schnell","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0130","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.12113","article-title":"Co-expression patterns of immune checkpoint molecules in relation to PD-L1 expression","volume":"36","author":"Pal","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0135","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/s41598-020-60440-5","article-title":"Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma","volume":"10","author":"Dong","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tan.13872","article-title":"The immune checkpoints Cytotoxic T lymphocyte antigen-4 and Lymphocyte activation gene-3 expression is up-regulated in acute myeloid leukemia","volume":"96","author":"Radwan","year":"2020","journal-title":"Hla"},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.06.007_b0145","first-page":"e252","article-title":"Different aberrant expression pattern of immune checkpoint receptors in patients with PTCL and NK\/T-CL.14. Asia Pac","volume":"14","author":"Liao","year":"2018","journal-title":"J. Clin .Oncol."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0150","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.molonc.2016.09.004","article-title":"Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer","volume":"10","author":"Dai","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0155","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3109\/07357901003630934","article-title":"Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer","volume":"28","author":"Erfani","year":"2010","journal-title":"Cancer Invest."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0160","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3892\/mmr.2014.2699","article-title":"Ectopic expression of B and T lymphocyte attenuator in gastric cancer: a potential independent prognostic factor in patients with gastric cancer","volume":"11","author":"Feng","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12967-020-02469-8","article-title":"Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8(+)T cells in hepatocellular carcinoma using multiplex quantitative analysis","volume":"18","author":"Guo","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3892\/ol.2021.12587","article-title":"Expression of immune check point gene TIM-3 in patients newly diagnosed with acute myeloid leukemia: Significance and impact on outcome","volume":"21","author":"Kamal","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0175","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.athoracsur.2019.12.017","article-title":"Significance of TIM-3 expression in resected esophageal squamous cell carcinoma","volume":"109","author":"Zhao","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.clinbiochem.2021.06.007_b0180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.20892\/j.issn.2095-3941.2018.0306","article-title":"LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival","volume":"16","author":"Que","year":"2019","journal-title":"Cancer Biol. Med."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021001764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021001764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:56:56Z","timestamp":1757865416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021001764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":36,"alternative-id":["S0009912021001764"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.06.007","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}